Developmental stuttering and Parkinson's disease: the effects of levodopa treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10329754.
- Also identified by PMC identifier 1736378.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The effects of dopamine on developmental stuttering was studied in a 44 year old man with developmental stuttering and Parkinson's disease during three levodopa "on" periods and three "off" periods. When compared with the "off" periods, during the "on"' periods he demonstrated an increase of speech dysfluencies. These findings lend support to the dopamine hypothesis of developmental stuttering.
Medical subject headings
- Levodopa
- Parkinson Disease
- Stuttering